Home/Clinical Research, Neurology, Psychiatry/Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Heterogeneity of Alzheimer's Disease

Consequence for drug trials?

Gayatri Devi and Phillip Scheltens

BMC Alzheimer’s Research & Therapy 2018 10:122

https://doi.org/10.1186/s13195-018-0455-y, © 2018, the Author(s).

Devi, G., & Scheltens, P. (2018). Heterogeneity of Alzheimer’s disease: consequence for drug trials? Alzheimer’s Research & Therapy, 10(1), 122. https://doi.org/10.1186/s13195-018-0455-y

IF YOU LIKE THIS TOPIC, PLEASE JOIN OUR COMMUNITY

We will send new articles straight to your inbox!

We don’t allow SPAM.  Your email will be safe with us.  See our privacy policy.